SAGE Advice

Make way for the Age of SAGE. Introduced in 1995 by Kenneth Kinzler and Bert Vogelstein of the Johns Hopkins University in Baltimore, Md., SAGE™, or Serial Analysis of Gene Expression, is a quantitative method of gene expression analysis based on the idea that an mRNA transcript can be identified by just a short (9-14 base pair) subfragment.1 In the technique, mRNA is isolated, copied into cDNA, tagged at the 3' end with biotin, and then cut with a restriction enzyme. The tagged fragmen

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In the technique, mRNA is isolated, copied into cDNA, tagged at the 3' end with biotin, and then cut with a restriction enzyme. The tagged fragments are then isolated with streptavidin-coated beads, amplified, ligated into a single molecule, and sequenced. The enumeration of each "tag" indicates the level of expression of the gene it represents. The technique has several advantages over microarray analysis, as it can detect genes with no prior sequence information, is sensitive for low-abundance genes, and provides digital quantification of gene expression. The public database SAGEmap (www.ncbi.nlm.nih.gov/sage) is available to compare data with known gene expression profiles.

Until recently, researchers using the SAGE technique have had to follow a complex and labor-intensive protocol involving specialized buffers that were not commercially available. "A recent survey suggested that 50 percent of individuals who try SAGE technology from 'scratch' fail," says Amy Duncan, product manager at Invitrogen. "Problems may arise ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies